Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 10x Genomics, Inc.TXG · Entity 2172 | Director · See Remarks | August 24, 2026 | August 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
10x Genomics, Inc.
Report date August 24, 2026 · Filed August 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 488,182 |
Reported balance
After 2026-08-24 transaction · row 1
1 source rowRow 1 · 2026-08-24 · Sale · Disposed 13,818 · Balance 488,182 F1: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2: This transaction was executed in multiple trades at prices ranging from $63.0088 to $63.78, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2: This transaction was executed in multiple trades at prices ranging from $63.0088 to $63.78, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 24, 2026 Filed Aug 26, 2026 20:43 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 13,818 | $63.02 | $870,860.10 |
DisclosureSEC source: 0001610717-26-000390 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 488,182 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. F2 · price: This transaction was executed in multiple trades at prices ranging from $63.0088 to $63.78, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| May 22, 2026 Filed May 27, 2026 21:56 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 11,595 | $24.44 | $283,399.19 |
DisclosureSEC source: 0001610717-26-000163 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 502,000 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:23 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantClass A Common Stock | 88,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-26-000076 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 513,595 F1 · shares: Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2026, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:51 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 7,826 | $18.58 | $145,378.91 |
DisclosureSEC source: 0001610717-26-000068 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 424,779 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 22:24 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 8,283 | $19.00 | $157,362.92 |
DisclosureSEC source: 0001610717-25-000399 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 432,605 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 20:12 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 7,486 | $13.79 | $103,209.48 |
DisclosureSEC source: 0001610717-25-000319 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 440,888 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:07 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 7,485 | $8.30 | $62,120.26 |
DisclosureSEC source: 0001610717-25-000143 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 448,374 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 21:35 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantClass A Common Stock | 120,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000074 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 455,859 F1 · shares: Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2025, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 22:43 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 4,573 | $11.07 | $50,602.99 |
DisclosureSEC source: 0001610717-25-000037 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,324 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 21:52 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 5,807 | $13.69 | $79,485.05 |
DisclosureSEC source: 0001610717-24-000529 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,897 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 21:04 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 4,351 | $22.53 | $98,026.72 |
DisclosureSEC source: 0001610717-24-000454 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,704 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 22, 2024 Filed May 23, 2024 23:52 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 4,087 | $24.30 | $99,328.81 |
DisclosureSEC source: 0001610717-24-000257 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,055 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 21:16 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantClass A Common Stock | 71,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-24-000185 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,142 F1 · shares: Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2024, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:12 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 2,613 | $46.34 | $121,097.66 |
DisclosureSEC source: 0001610717-24-000091 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,059 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 21:19 UTC | 10x Genomics, Inc. TXG · Entity 2172 | Exercise / conversionStock Option (right to buy) · Derivative | 8,334 | $0.00 Strike: $11.48 | $0.00 |
DisclosureSEC source: 0001610717-23-000427 · form4.xml · derivative · entry 2 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,978 Underlying: Class A Common Stock · 8,334 shares Expires 2029-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All of the shares subject to the option are fully vested and exercisable as of the date hereof. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 21:19 UTC | 10x Genomics, Inc. TXG · Entity 2172 | Exercise / conversionClass A Common Stock | 8,334 | $11.48 | $95,674.32 |
DisclosureSEC source: 0001610717-23-000427 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 23:16 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 3,449 | $43.34 | $149,468.28 |
DisclosureSEC source: 0001610717-23-000366 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,338 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 22, 2023 Filed Aug 24, 2023 21:08 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 3,449 | $45.78 | $157,899.01 |
DisclosureSEC source: 0001610717-23-000235 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,787 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 20:23 UTC | 10x Genomics, Inc. TXG · Entity 2172 | Exercise / conversionStock Option (right to buy) · Derivative | 6,970 | $0.00 Strike: $11.48 | $0.00 |
DisclosureSEC source: 0001610717-23-000222 · form4.xml · derivative · entry 4 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,312 Underlying: Class A Common Stock · 6,970 shares Expires 2029-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All of the shares subject to the option are fully vested and exercisable as of the date hereof. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 20:23 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 5,243 | $62.36 | $326,933.03 |
DisclosureSEC source: 0001610717-23-000222 · form4.xml · nonDerivative · entry 3 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 284,236 F1 · kind: The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $62.12 to $62.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 20:23 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 1,727 | $61.77 | $106,679.21 |
DisclosureSEC source: 0001610717-23-000222 · form4.xml · nonDerivative · entry 2 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 289,479 F1 · kind: The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $61.12 to $62.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 20:23 UTC | 10x Genomics, Inc. TXG · Entity 2172 | Exercise / conversionClass A Common Stock | 6,970 | $11.48 | $80,015.60 |
DisclosureSEC source: 0001610717-23-000222 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 291,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:31 UTC | 10x Genomics, Inc. TXG · Entity 2172 | Exercise / conversionStock Option (right to buy) · Derivative | 968 | $0.00 Strike: $11.48 | $0.00 |
DisclosureSEC source: 0001610717-23-000214 · form4.xml · derivative · entry 5 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,282 Underlying: Class A Common Stock · 968 shares Expires 2029-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: All of the shares subject to the option are fully vested and exercisable as of the date hereof. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:31 UTC | 10x Genomics, Inc. TXG · Entity 2172 | Exercise / conversionStock Option (right to buy) · Derivative | 12,972 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001610717-23-000214 · form4.xml · derivative · entry 4 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 12,972 shares Expires 2028-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: All of the shares subject to the option are fully vested and exercisable as of the date hereof. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:31 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 13,940 | $60.03 | $836,833.53 |
DisclosureSEC source: 0001610717-23-000214 · form4.xml · nonDerivative · entry 3 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 284,236 F1 · kind: The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $60.00 to $60.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:31 UTC | 10x Genomics, Inc. TXG · Entity 2172 | Exercise / conversionClass A Common Stock | 968 | $11.48 | $11,112.64 |
DisclosureSEC source: 0001610717-23-000214 · form4.xml · nonDerivative · entry 2 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 298,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 21:31 UTC | 10x Genomics, Inc. TXG · Entity 2172 | Exercise / conversionClass A Common Stock | 12,972 | $5.04 | $65,378.88 |
DisclosureSEC source: 0001610717-23-000214 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 297,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2023 Filed May 25, 2023 21:49 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 791 | $55.06 | $43,553.41 |
DisclosureSEC source: 0001610717-23-000066 · form4.xml · nonDerivative · entry 4 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 284,236 F1 · shares: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 23, 2023 Filed May 25, 2023 21:49 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 735 | $55.06 | $40,471.38 |
DisclosureSEC source: 0001610717-23-000066 · form4.xml · nonDerivative · entry 3 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,027 F1 · shares: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 23, 2023 Filed May 25, 2023 21:49 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 619 | $55.06 | $34,082.45 |
DisclosureSEC source: 0001610717-23-000066 · form4.xml · nonDerivative · entry 2 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,762 F1 · shares: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 23, 2023 Filed May 25, 2023 21:49 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 243 | $55.06 | $13,379.43 |
DisclosureSEC source: 0001610717-23-000066 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,381 F1 · shares: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 22:25 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantPerformance- based Restricted Stock Units · Derivative | 18,194 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-013505 · form4.xml · derivative · entry 3 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,194 Underlying: Class A Common Stock · 18,194 shares Expires 2028-04-01 F3 · derivative.exercise_price: Each Performance-Based Restricted Stock Unit ("PSU") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs shall vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date. F3 · derivative.exercise_date: Each Performance-Based Restricted Stock Unit ("PSU") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs shall vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 22:25 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantStock Option (right to buy) · Derivative | 36,387 | $0.00 Strike: $50.10 | $0.00 |
DisclosureSEC source: 0001140361-23-013505 · form4.xml · derivative · entry 2 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,387 Underlying: Class A Common Stock · 36,387 shares Expires 2033-03-21 F2 · derivative.exercise_date: 1/48th of the total number of shares subject to the option vest on each monthly anniversary measured from April 1, 2023, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 22:25 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantClass A Common Stock | 36,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-013505 · form4.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,624 F1 · shares: Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2023, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 22:51 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 1,742 | $47.75 | $83,186.25 |
DisclosureSEC source: 0001567619-23-003780 · doc1.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,237 F1 · shares: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:46 UTC | 10x Genomics, Inc. TXG · Entity 2172 | Exercise / conversionStock Option (right to buy) · Derivative | 34,266 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001567619-22-021727 · doc1.xml · derivative · entry 2 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,972 Underlying: Class A Common Stock · 34,266 shares Expires 2028-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All of the shares subject to the option are fully vested and exercisable as of the date hereof. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:46 UTC | 10x Genomics, Inc. TXG · Entity 2172 | Exercise / conversionClass A Common Stock | 34,266 | $5.04 | $172,700.64 |
DisclosureSEC source: 0001567619-22-021727 · doc1.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 22:02 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 1,087 | $34.07 | $37,031.81 |
DisclosureSEC source: 0001567619-22-020870 · doc1.xml · nonDerivative · entry 3 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,713 F1 · shares: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 22:02 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 915 | $34.07 | $31,172.22 |
DisclosureSEC source: 0001567619-22-020870 · doc1.xml · nonDerivative · entry 2 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,800 F1 · shares: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 22:02 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 359 | $34.07 | $12,229.59 |
DisclosureSEC source: 0001567619-22-020870 · doc1.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,715 F1 · shares: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 21:33 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantPerformance-based Restricted Stock Units · Derivative | 67,655 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-017564 · doc1.xml · derivative · entry 3 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,655 Underlying: Class A Common Stock · 67,655 shares Expires 2026-09-14 F3 · derivative.exercise_price: Each Performance-Based Restricted Stock Unit ("PSU") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date. F3 · derivative.exercise_date: Each Performance-Based Restricted Stock Unit ("PSU") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 21:33 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantStock Option (right to buy) · Derivative | 67,655 | $0.00 Strike: $33.67 | $0.00 |
DisclosureSEC source: 0001567619-22-017564 · doc1.xml · derivative · entry 2 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,655 Underlying: Class A Common Stock · 67,655 shares Expires 2032-09-14 F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from September 14, 2022, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 21:33 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantClass A Common Stock | 33,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-017564 · doc1.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,074 F1 · shares: Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs vest on each quarterly anniversary measured from August 21, 2022, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 20:58 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 1,292 | $35.19 | $45,467.16 |
DisclosureSEC source: 0001567619-22-016676 · doc1.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,246 F1 · shares: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| May 23, 2022 Filed May 25, 2022 22:30 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 1,264 | $48.76 | $61,637.19 |
DisclosureSEC source: 0001567619-22-011712 · doc1.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,538 F1 · shares: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| March 22, 2022 Filed Mar 24, 2022 21:17 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantStock Option (Right to Buy) · Derivative | 71,189 | $0.00 Strike: $69.56 | $0.00 |
DisclosureSEC source: 0001567619-22-007442 · doc1.xml · derivative · entry 2 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,189 Underlying: Class A Common Stock · 71,189 shares Expires 2032-03-22 F2 · derivative.exercise_date: This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one forty-eighth of the shares on May 1, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| March 22, 2022 Filed Mar 24, 2022 21:17 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantClass A Common Stock | 28,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-007442 · doc1.xml · nonDerivative · entry 1 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,802 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-sixteenth of the RSUs shall vest on May 21, 2022 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:40 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GiftClass B Common Stock · Derivative | 133,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-005522 · doc1.xml · derivative · entry 4 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 133,500 Underlying: Class A Common Stock · 133,500 shares Expires not disclosed F2 · security: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F2 · derivative.underlying: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F5 · ownership.nature: Shares held by Irrevocable Hindson Descendants' Trust FBO BLH DTD 12/15/2021. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:40 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GiftClass B Common Stock · Derivative | 133,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-005522 · doc1.xml · derivative · entry 3 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 133,500 Underlying: Class A Common Stock · 133,500 shares Expires not disclosed F2 · security: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F2 · derivative.underlying: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F4 · ownership.nature: Shares held by Irrevocable Hindson Descendants' Trust FBO BAH DTD 12/15/2021. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:40 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GiftClass B Common Stock · Derivative | 267,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-005522 · doc1.xml · derivative · entry 2 Hindson Benjamin J. · CIK 0001786391 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,733,000 Underlying: Class A Common Stock · 267,000 shares Expires not disclosed F2 · security: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F2 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F2 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F2 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F2 · derivative.underlying: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon transfer, whether or not for value (subject to certain exceptions) and upon the occurrence of certain other events set forth in the Issuer's Amended and Restated Certificate of Incorporation. F3 · ownership.nature: Shares held by Hindson Family Revocable Trust DTD 11/04/2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.